- Home
- TTOO vs GNTA Comparison
TTOO vs GNTA Comparison
Compare TTOO & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- GNTA
- Stock Information
- Founded
- TTOO 2006
- GNTA 2014
- Country
- TTOO United States
- GNTA Italy
- Employees
- TTOO N/A
- GNTA N/A
- Industry
- TTOO Medical/Dental Instruments
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTOO Health Care
- GNTA Health Care
- Exchange
- TTOO Nasdaq
- GNTA Nasdaq
- Market Cap
- TTOO 36.4M
- GNTA 67.4M
- IPO Year
- TTOO 2014
- GNTA 2021
- Fundamental
- Price
- TTOO $0.97
- GNTA $5.34
- Analyst Decision
- TTOO Hold
- GNTA Strong Buy
- Analyst Count
- TTOO 1
- GNTA 1
- Target Price
- TTOO $5.00
- GNTA $25.00
- AVG Volume (30 Days)
- TTOO 710.5K
- GNTA 28.4K
- Earning Date
- TTOO 11-13-2024
- GNTA 01-01-0001
- Dividend Yield
- TTOO N/A
- GNTA N/A
- EPS Growth
- TTOO N/A
- GNTA N/A
- EPS
- TTOO N/A
- GNTA N/A
- Revenue
- TTOO $7,164,000.00
- GNTA N/A
- Revenue This Year
- TTOO $50.31
- GNTA N/A
- Revenue Next Year
- TTOO $117.92
- GNTA N/A
- P/E Ratio
- TTOO N/A
- GNTA N/A
- Revenue Growth
- TTOO N/A
- GNTA N/A
- 52 Week Low
- TTOO $0.90
- GNTA $2.20
- 52 Week High
- TTOO $8.38
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- GNTA 56.89
- Support Level
- TTOO $0.90
- GNTA $4.89
- Resistance Level
- TTOO $1.86
- GNTA $6.20
- Average True Range (ATR)
- TTOO 0.15
- GNTA 0.70
- MACD
- TTOO -0.00
- GNTA -0.06
- Stochastic Oscillator
- TTOO 5.72
- GNTA 37.32
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.